PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

Clinical trial NCT07175480 · RECRUITING

Trial details

NCT number: NCT07175480
Sponsor: Jinling Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)

Start date: 2025-01-24
Primary completion: 2027-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.